oral semaglutide fda approval The #FDA approved the first GLP-1 receptor agonist, (#Wegovy pill), for chronic weight management in adults with obesity or overweight with comorbidities, offering a noninjectable alternative with significant weight loss FDA Approves First ORAL GLP-1
Description
Not everyone responds equally to GLP-1 medications like Ozempic

Free protein calculator for weight loss on a GLP-1
Discover how semaglutide supports weight loss by controlling appetite & boosting metabolism

However, its also known to cause a less-than-ideal side effect: diarrhea

Made in the USA Produced in a GMP-compliant, FDA-registered facility and third-party tested for purity and quality
